Selected research
Industry Growth & Trends
Global Anti-Thyroid Drugs Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Anti-Thyroid Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Anti-Thyroid Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Anti-Thyroid Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anti-Thyroid Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Anti-Thyroid Drugs market include Merck and Co., Mylan N.V., GlaxoSmithKline plc, AbbVie and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Anti-Thyroid Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Anti-Thyroid Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-Thyroid Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-Thyroid Drugs.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Anti-Thyroid Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Anti-Thyroid Drugs Market by Company
Merck and Co.
Mylan N.V.
GlaxoSmithKline plc
AbbVie
Abbott Laboratories
Anti-Thyroid Drugs Segment by Type
Oral
Intravenous
Others
Anti-Thyroid Drugs Segment by Application
Online
Offline
Anti-Thyroid Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Thyroid Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Thyroid Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Thyroid Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Anti-Thyroid Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Intravenous
- Others
Applications
- Online
- Offline
Companies covered
- Merck and Co.
- Mylan N.V.
- GlaxoSmithKline plc
- AbbVie
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Anti-Thyroid Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Anti-Thyroid Drugs Market Size by Region (2021-2032)
- 1.4.1 Global Anti-Thyroid Drugs Market Size by Region (2021-2026)
- 1.4.2 Global Anti-Thyroid Drugs Market Size by Region (2027-2032)
- 1.5 Key Regions Anti-Thyroid Drugs Market Size (2021-2032)
- 1.5.1 North America Anti-Thyroid Drugs Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Anti-Thyroid Drugs Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Anti-Thyroid Drugs Market Size Growth Rate (2021-2032)
- 1.5.4 South America Anti-Thyroid Drugs Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Anti-Thyroid Drugs Market Size Growth Rate (2021-2032)
2 Anti-Thyroid Drugs Market by Type
- 2.1 Type Introduction
- 2.1.1 Oral
- 2.1.2 Intravenous
- 2.1.3 Others
- 2.2 Global Anti-Thyroid Drugs Market Size by Type
- 2.2.1 Global Anti-Thyroid Drugs Market Size Overview by Type (2021-2032)
- 2.2.2 Global Anti-Thyroid Drugs Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Anti-Thyroid Drugs Market Size Forecasted by Type (2027-2032)
- 2.3 Global Anti-Thyroid Drugs Market Size by Regions
- 2.3.1 North America Anti-Thyroid Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Anti-Thyroid Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Anti-Thyroid Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Anti-Thyroid Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Anti-Thyroid Drugs Market Size Breakdown by Type (2021-2026)
3 Anti-Thyroid Drugs Market by Application
- 3.1 Type Introduction
- 3.1.1 Online
- 3.1.2 Offline
- 3.2 Global Anti-Thyroid Drugs Market Size by Application
- 3.2.1 Global Anti-Thyroid Drugs Market Size Overview by Application (2021-2032)
- 3.2.2 Global Anti-Thyroid Drugs Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Anti-Thyroid Drugs Market Size Forecasted by Application (2027-2032)
- 3.3 Global Anti-Thyroid Drugs Market Size by Regions
- 3.3.1 North America Anti-Thyroid Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Anti-Thyroid Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Anti-Thyroid Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Anti-Thyroid Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Anti-Thyroid Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Anti-Thyroid Drugs Industry Trends
- 4.2 Anti-Thyroid Drugs Industry Drivers
- 4.3 Anti-Thyroid Drugs Industry Opportunities and Challenges
- 4.4 Anti-Thyroid Drugs Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Anti-Thyroid Drugs Revenue (2021-2026)
- 5.2 Global Anti-Thyroid Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Anti-Thyroid Drugs Key Company Headquarters & Area Served
- 5.4 Global Anti-Thyroid Drugs Company, Product Type & Application
- 5.5 Global Anti-Thyroid Drugs Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Anti-Thyroid Drugs Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Anti-Thyroid Drugs Players Market Share by Revenue in 2025
- 5.6.3 2025 Anti-Thyroid Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Merck and Co.
- 6.1.1 Merck and Co. Company Information
- 6.1.2 Merck and Co. Business Overview
- 6.1.3 Merck and Co. Anti-Thyroid Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Merck and Co. Anti-Thyroid Drugs Product Portfolio
- 6.1.5 Merck and Co. Recent Developments
- 6.2 Mylan N.V.
- 6.2.1 Mylan N.V. Company Information
- 6.2.2 Mylan N.V. Business Overview
- 6.2.3 Mylan N.V. Anti-Thyroid Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Mylan N.V. Anti-Thyroid Drugs Product Portfolio
- 6.2.5 Mylan N.V. Recent Developments
- 6.3 GlaxoSmithKline plc
- 6.3.1 GlaxoSmithKline plc Company Information
- 6.3.2 GlaxoSmithKline plc Business Overview
- 6.3.3 GlaxoSmithKline plc Anti-Thyroid Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 GlaxoSmithKline plc Anti-Thyroid Drugs Product Portfolio
- 6.3.5 GlaxoSmithKline plc Recent Developments
- 6.4 AbbVie
- 6.4.1 AbbVie Company Information
- 6.4.2 AbbVie Business Overview
- 6.4.3 AbbVie Anti-Thyroid Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 AbbVie Anti-Thyroid Drugs Product Portfolio
- 6.4.5 AbbVie Recent Developments
- 6.5 Abbott Laboratories
- 6.5.1 Abbott Laboratories Company Information
- 6.5.2 Abbott Laboratories Business Overview
- 6.5.3 Abbott Laboratories Anti-Thyroid Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Abbott Laboratories Anti-Thyroid Drugs Product Portfolio
- 6.5.5 Abbott Laboratories Recent Developments
7 North America
- 7.1 North America Anti-Thyroid Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Anti-Thyroid Drugs Market Size by Country (2021-2026)
- 7.3 North America Anti-Thyroid Drugs Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Anti-Thyroid Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Anti-Thyroid Drugs Market Size by Country (2021-2026)
- 8.3 Europe Anti-Thyroid Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Anti-Thyroid Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Anti-Thyroid Drugs Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Anti-Thyroid Drugs Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Anti-Thyroid Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Anti-Thyroid Drugs Market Size by Country (2021-2026)
- 10.3 South America Anti-Thyroid Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Anti-Thyroid Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Anti-Thyroid Drugs Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Anti-Thyroid Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst